Cellectis (CLLS) Stock Price & Financial Analysis
Cellectis Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Cellectis
What is the current stock price for CLLS?
As of the latest trading session, CLLS stock trades at $2.98. The 52-week range is $1.41–$5.48, with a day range of $2.88–$3.15.
What is the P/E ratio for CLLS?
The P/E ratio (Price-to-Earnings) for CLLS is shown in the Key Statistics section. This valuation metric helps compare Cellectis S.A. to industry peers.
Does CLLS pay dividends?
Cellectis does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CLLS?
Based on 1 analyst, the consensus for CLLS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CLLS?
Cellectis's market capitalization is $299.6M, classifying it as a micro-cap company. Cellectis operates in the Healthcare sector within the Biotechnology industry.